Article
Stat4 rs7574865 polymorphism promotes the occurrence and progression of hepatocellular carcinoma via the Stat4/CYP2E1/FGL2 pathway.
Cell death & disease - 8 Feb 2022
Wang Caie, Gao Na, Yang Lukui, Guo Yuanyuan, Fang Yan, Wang Tong, Xu Chen, Li Gui Fang, Zhou Jun, Zhang Yunfei, Wen Qiang, Qiao Hailing
Abstract excerpt
Although there are many studies on the relationship between genetic polymorphisms and the incidence of diseases, mechanisms are rarely known. We report the mechanism by which signal transducer and activator of transcription 4 (stat4) rs7574865 promotes the occurrence and progression of hepatocellular carcinoma (HCC). We found that the GG genotype at stat4 rs7574865 was a risk genotype, and STAT4 levels in serum...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
